|
RFC5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.782000E-01 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.308600E-01 |
| Normal-vs-Stage2 |
7.407800E-01 |
| Normal-vs-Stage3 |
7.656000E-01 |
| Normal-vs-Stage4 |
1.383580E-01 |
| Stage1-vs-Stage2 |
4.786000E-01 |
| Stage1-vs-Stage3 |
4.221600E-01 |
| Stage1-vs-Stage4 |
1.972970E-01 |
| Stage2-vs-Stage3 |
9.432600E-01 |
| Stage2-vs-Stage4 |
1.177780E-01 |
| Stage3-vs-Stage4 |
1.034570E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.901200E-01 |
| Normal-vs-AfricanAmerican |
4.257000E-01 |
| Normal-vs-Asian |
4.607800E-01 |
| Caucasian-vs-AfricanAmerican |
1.750180E-01 |
| Caucasian-vs-Asian |
3.750400E-01 |
| AfricanAmerican-vs-Asian |
2.329800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.386600E-01 |
| Normal-vs-Female |
5.769200E-01 |
| Male-vs-Female |
8.929800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.780800E-01 |
| Normal-vs-Age(41-60Yrs) |
5.580400E-01 |
| Normal-vs-Age(61-80Yrs) |
4.535800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.331230E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.503800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.146200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.212000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.407800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.456630E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.560390E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
3.558600E-01 |
| Normal-vs-Grade 2 |
1.983010E-01 |
| Normal-vs-Grade 3 |
6.960000E-01 |
| Normal-vs-Grade 4 |
6.525600E-01 |
| Grade 1-vs-Grade 2 |
8.134200E-01 |
| Grade 1-vs-Grade 3 |
3.913400E-01 |
| Grade 1-vs-Grade 4 |
7.205000E-01 |
| Grade 2-vs-Grade 3 |
6.186200E-02 |
| Grade 2-vs-Grade 4 |
8.232000E-01 |
| Grade 3-vs-Grade 4 |
4.990000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.870200E-01 |
| Normal-vs-ccB subtype |
3.425200E-01 |
| ccA subtype-vs-ccB subtype |
4.920400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.519000E-01 |
| Normal-vs-N1 |
1.992030E-01 |
| N0-vs-N1 |
2.199000E-01 |
|
|
